Richard Formica, MD
Professor of Medicine (Nephrology) and Professor of Surgery (Transplant); Director of Transplant Medicine, Internal Medicine; Director Outpatient Transplantation Service, Transplantation Center; Medical Director Adult Kidney Transplantation, Transplantation Center
Research & Publications
Biography
News
Coauthors
Selected Publications
- A one-day centralized work-up for kidney transplant recipient candidates: a quality improvement report.Formica RN, Barrantes F, Asch WS, Bia MJ, Coca S, Kalyesubula R, McCloskey B, Leary T, Arvelakis A, Kulkarni S. A one-day centralized work-up for kidney transplant recipient candidates: a quality improvement report. American Journal Of Kidney Diseases : The Official Journal Of The National Kidney Foundation 2012, 60:288-94.
- Kidney transplantation and HIV: does recipient privacy outweigh the donor's right to information?Formica RN, Asch WS, Wagner KR, Kulkarni S. Kidney transplantation and HIV: does recipient privacy outweigh the donor's right to information? Clinical Journal Of The American Society Of Nephrology : CJASN 2010, 5:924-8.
- A randomized trial comparing losartan with amlodipine as initial therapy for hypertension in the early post-transplant period.Formica RN, Friedman AL, Lorber MI, Smith JD, Eisen T, Bia MJ. A randomized trial comparing losartan with amlodipine as initial therapy for hypertension in the early post-transplant period. Nephrology, Dialysis, Transplantation : Official Publication Of The European Dialysis And Transplant Association - European Renal Association 2006, 21:1389-94.
- The kidney allocation system.Friedewald JJ, Samana CJ, Kasiske BL, Israni AK, Stewart D, Cherikh W, Formica RN. The kidney allocation system. The Surgical Clinics Of North America 2013, 93:1395-406.
- Multicenter validation of urinary CXCL9 as a risk-stratifying biomarker for kidney transplant injury.Hricik DE, Nickerson P, Formica RN, Poggio ED, Rush D, Newell KA, Goebel J, Gibson IW, Fairchild RL, Riggs M, Spain K, Ikle D, Bridges ND, Heeger PS. Multicenter validation of urinary CXCL9 as a risk-stratifying biomarker for kidney transplant injury. American Journal Of Transplantation : Official Journal Of The American Society Of Transplantation And The American Society Of Transplant Surgeons 2013, 13:2634-44.
- Written informed consent for living kidney donors: practices and compliance with CMS and OPTN requirements.Thiessen C, Kim YA, Formica R, Bia M, Kulkarni S. Written informed consent for living kidney donors: practices and compliance with CMS and OPTN requirements. American Journal Of Transplantation : Official Journal Of The American Society Of Transplantation And The American Society Of Transplant Surgeons 2013, 13:2713-21.
- Rapid reconstitution of Epstein-Barr virus-specific T lymphocytes following allogeneic stem cell transplantation.Marshall NA, Howe JG, Formica R, Krause D, Wagner JE, Berliner N, Crouch J, Pilip I, Cooper D, Blazar BR, Seropian S, Pamer EG. Rapid reconstitution of Epstein-Barr virus-specific T lymphocytes following allogeneic stem cell transplantation. Blood 2000, 96:2814-21.
- Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers used for the treatment of hypertension appear to be safe in the early posttransplant period.Formica RN, Friedman AL, Lorber MI, Bia MJ. Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers used for the treatment of hypertension appear to be safe in the early posttransplant period. Transplantation Proceedings 2004, 36:2675-8.
- Immunosuppressive therapy protocols in kidney transplantation in adults.Karamehić J, Lorber M, Formica R, Gavrankapetanović F, Heljić B, Subasić D, Zecević L. Immunosuppressive therapy protocols in kidney transplantation in adults. Bosnian Journal Of Basic Medical Sciences / Udruz¿enje Basic¿nih Mediciniskih Znanosti = Association Of Basic Medical Sciences 2006, 6:43-7.
- Medication errors in the outpatient setting: classification and root cause analysis.Friedman AL, Geoghegan SR, Sowers NM, Kulkarni S, Formica RN. Medication errors in the outpatient setting: classification and root cause analysis. Archives Of Surgery (Chicago, Ill. : 1960) 2007, 142:278-83; discussion 284.
- HCV response in patients with end stage renal disease treated with combination pegylated interferon alpha-2a and ribavirin.Hakim W, Sheikh S, Inayat I, Caldwell C, Smith D, Lorber M, Friedman A, Jain D, Bia M, Formica R, Mehal W. HCV response in patients with end stage renal disease treated with combination pegylated interferon alpha-2a and ribavirin. Journal Of Clinical Gastroenterology 2009, 43:477-81.
- Association between delayed graft function and allograft and patient survival: a systematic review and meta-analysis.Yarlagadda SG, Coca SG, Formica RN, Poggio ED, Parikh CR. Association between delayed graft function and allograft and patient survival: a systematic review and meta-analysis. Nephrology, Dialysis, Transplantation : Official Publication Of The European Dialysis And Transplant Association - European Renal Association 2009, 24:1039-47.
- Renal ultrasonography in the evaluation of acute kidney injury: developing a risk stratification framework.Licurse A, Kim MC, Dziura J, Forman HP, Formica RN, Makarov DV, Parikh CR, Gross CP. Renal ultrasonography in the evaluation of acute kidney injury: developing a risk stratification framework. Archives Of Internal Medicine 2010, 170:1900-7.
- Significant sirolimus and dronedarone interaction in a kidney transplant recipient.Tichy EM, Medwid AJ, Mills EA, Formica RN, Kulkarni S. Significant sirolimus and dronedarone interaction in a kidney transplant recipient. The Annals Of Pharmacotherapy 2010, 44:1338-41.
- Combined liver kidney transplantation: critical analysis of a single-center experience.Cimsit B, Schilsky M, Moini M, Cartiera K, Arvelakis A, Kulkarni S, Formica R, Caldwell C, Taddei T, Asch W, Emre S. Combined liver kidney transplantation: critical analysis of a single-center experience. Transplantation Proceedings 2011, 43:901-4.
- Renal transplantation for nephrogenic systemic fibrosis: a case report and review of the literature.Cuffy MC, Singh M, Formica R, Simmons E, Abu Alfa AK, Carlson K, Girardi M, Cowper SE, Kulkarni S. Renal transplantation for nephrogenic systemic fibrosis: a case report and review of the literature. Nephrology, Dialysis, Transplantation : Official Publication Of The European Dialysis And Transplant Association - European Renal Association 2011, 26:1099-101.
- Accepting a donor kidney: an evaluation of patients' and transplant surgeons' priorities.Solomon DA, Rabidou N, Kulkarni S, Formica R, Fraenkel L. Accepting a donor kidney: an evaluation of patients' and transplant surgeons' priorities. Clinical Transplantation 2011, 25:786-93.
- When and how should immunosuppression be tapered for the failed renal allograft?Formica RN. When and how should immunosuppression be tapered for the failed renal allograft? Seminars In Dialysis 2011, 24:371-3.
- Multidetector CT angiography in living donor renal transplantation: accuracy and discrepancies in right venous anatomy.Kulkarni S, Emre S, Arvelakis A, Asch W, Bia M, Formica R, Israel G. Multidetector CT angiography in living donor renal transplantation: accuracy and discrepancies in right venous anatomy. Clinical Transplantation 2011, 25:77-82.
- An analysis of measured and estimated creatinine clearance rates in normal weight, overweight, and obese patients with gynecologic cancers.Nelson WK, Formica RN, Cooper DL, Schwartz PE, Rutherford TJ. An analysis of measured and estimated creatinine clearance rates in normal weight, overweight, and obese patients with gynecologic cancers. Journal Of Oncology Pharmacy Practice : Official Publication Of The International Society Of Oncology Pharmacy Practitioners 2012, 18:323-32.
- A renal variant of Fabry disease: A case with a novel Gal A hemizygote mutation.H Mukdsi J, Gutiérrez S, Barrón B, Novoa P, Fernández S, de Diller AB, I Torres A, Formica RN, Orías M. A renal variant of Fabry disease: A case with a novel Gal A hemizygote mutation. Journal Of Nephropathology 2012, 1:194-7.
- Clinical outcomes associated with conversion from brand-name to generic tacrolimus in hospitalized kidney transplant recipients.Heavner MS, Tichy EM, Yazdi M, Formica RN, Kulkarni S, Emre S. Clinical outcomes associated with conversion from brand-name to generic tacrolimus in hospitalized kidney transplant recipients. American Journal Of Health-system Pharmacy : AJHP : Official Journal Of The American Society Of Health-System Pharmacists 2013, 70:1507-12.
- Cytomegalovirus glomerulopathy and cytomegalovirus interstitial nephritis on sequential transplant kidney biopsies.Vichot AA, Formica RN, Moeckel GW. Cytomegalovirus glomerulopathy and cytomegalovirus interstitial nephritis on sequential transplant kidney biopsies. American Journal Of Kidney Diseases : The Official Journal Of The National Kidney Foundation 2014, 63:536-9.
- New national allocation policy for deceased donor kidneys in the United States and possible effect on patient outcomes.Israni AK, Salkowski N, Gustafson S, Snyder JJ, Friedewald JJ, Formica RN, Wang X, Shteyn E, Cherikh W, Stewart D, Samana CJ, Chung A, Hart A, Kasiske BL. New national allocation policy for deceased donor kidneys in the United States and possible effect on patient outcomes. Journal Of The American Society Of Nephrology : JASN 2014, 25:1842-8.
- Duration of prophylaxis against fungal infection in kidney transplant recipients.Guerra CM, Formica RN, Kulkarni S, Asch WS, Tichy EM. Duration of prophylaxis against fungal infection in kidney transplant recipients. Progress In Transplantation (Aliso Viejo, Calif.) 2015, 25:311-5.
- Association Between Organ Procurement Organization Social Network Centrality and Kidney Discard and Transplant Outcomes.Butala NM, King MD, Reitsma W, Formica RN, Abt PL, Reese PP, Parikh CR. Association Between Organ Procurement Organization Social Network Centrality and Kidney Discard and Transplant Outcomes. Transplantation 2015, 99:2617-24.
- Adverse Outcomes of Tacrolimus Withdrawal in Immune-Quiescent Kidney Transplant Recipients.Hricik DE, Formica RN, Nickerson P, Rush D, Fairchild RL, Poggio ED, Gibson IW, Wiebe C, Tinckam K, Bunnapradist S, Samaniego-Picota M, Brennan DC, Schröppel B, Gaber O, Armstrong B, Ikle D, Diop H, Bridges ND, Heeger PS. Adverse Outcomes of Tacrolimus Withdrawal in Immune-Quiescent Kidney Transplant Recipients. Journal Of The American Society Of Nephrology : JASN 2015, 26:3114-22.
- Opting out: confidentiality and availability of an 'alibi' for potential living kidney donors in the USA.Thiessen C, Kim YA, Formica R, Bia M, Kulkarni S. Opting out: confidentiality and availability of an 'alibi' for potential living kidney donors in the USA. Journal Of Medical Ethics 2015, 41:506-10.
- Simultaneous Liver-Kidney Allocation Policy: A Proposal to Optimize Appropriate Utilization of Scarce Resources.Formica RN, Aeder M, Boyle G, Kucheryavaya A, Stewart D, Hirose R, Mulligan D. Simultaneous Liver-Kidney Allocation Policy: A Proposal to Optimize Appropriate Utilization of Scarce Resources. American Journal Of Transplantation : Official Journal Of The American Society Of Transplantation And The American Society Of Transplant Surgeons 2016, 16:758-66.
- Changes in Deceased Donor Kidney Transplantation One Year After KAS Implementation.Stewart DE, Kucheryavaya AY, Klassen DK, Turgeon NA, Formica RN, Aeder MI. Changes in Deceased Donor Kidney Transplantation One Year After KAS Implementation. American Journal Of Transplantation : Official Journal Of The American Society Of Transplantation And The American Society Of Transplant Surgeons 2016, 16:1834-47.
- The Long-Term Follow-up and Support for Living Organ Donors: A Center-Based Initiative Founded on Developing a Community of Living Donors.Kulkarni S, Thiessen C, Formica RN, Schilsky M, Mulligan D, D'Aquila R. The Long-Term Follow-up and Support for Living Organ Donors: A Center-Based Initiative Founded on Developing a Community of Living Donors. American Journal Of Transplantation : Official Journal Of The American Society Of Transplantation And The American Society Of Transplant Surgeons 2016, 16:3385-3391.
- Belatacept and Eculizumab for Treatment of Calcineurin Inhibitor-induced Thrombotic Microangiopathy After Kidney Transplantation: Case Report.Merola J, Yoo PS, Schaub J, Smith JD, Rodriguez-Davalos MI, Tichy E, Mulligan DC, Asch W, Formica R, Kashgarian M, Kulkarni S. Belatacept and Eculizumab for Treatment of Calcineurin Inhibitor-induced Thrombotic Microangiopathy After Kidney Transplantation: Case Report. Transplantation Proceedings 2016, 48:3106-3108.
- Allocating Deceased Donor Kidneys to Sensitized Candidates.Formica RN. Allocating Deceased Donor Kidneys to Sensitized Candidates. Clinical Journal Of The American Society Of Nephrology : CJASN 2016, 11:377-8.
- What Is the Price of Altruism?Formica RN, Newell KA. What Is the Price of Altruism? American Journal Of Transplantation : Official Journal Of The American Society Of Transplantation And The American Society Of Transplant Surgeons 2016, 16:741-2.
- Simultaneous Liver-Kidney Allocation: Let's Not Make Perfect the Enemy of Good.Formica RN. Simultaneous Liver-Kidney Allocation: Let's Not Make Perfect the Enemy of Good. American Journal Of Transplantation : Official Journal Of The American Society Of Transplantation And The American Society Of Transplant Surgeons 2016, 16:2765.
- Simultaneous liver kidney transplantation.Formica RN. Simultaneous liver kidney transplantation. Current Opinion In Nephrology And Hypertension 2016, 25:577-582.
- Perspectives on the Strengths and Weaknesses of the National Kidney Allocation System.Formica RN. Perspectives on the Strengths and Weaknesses of the National Kidney Allocation System. Clinical Journal Of The American Society Of Nephrology : CJASN 2017, 12:2056.
- A critical assessment on kidney allocation systems.Formica RN. A critical assessment on kidney allocation systems. Transplantation Reviews (Orlando, Fla.) 2017, 31:61-67.
- Integrase strand transferase inhibitors: the preferred antiretroviral regimen in HIV-positive renal transplantation.Azar MM, Malinis MF, Moss J, Formica RN, Villanueva MS. Integrase strand transferase inhibitors: the preferred antiretroviral regimen in HIV-positive renal transplantation. International Journal Of STD & AIDS 2017, 28:447-458.
- Transition probabilities between changing sensitization levels, waitlist activity status and competing-risk kidney transplant outcomes using multi-state modeling.Kulkarni S, Hall I, Formica R, Thiessen C, Stewart D, Gan G, Greene E, Deng Y. Transition probabilities between changing sensitization levels, waitlist activity status and competing-risk kidney transplant outcomes using multi-state modeling. PloS One 2017, 12:e0190277.
- Utility of Applying Quality Assessment Tools for Kidneys With KDPI ≥80.Doshi MD, Reese PP, Hall IE, Schröppel B, Ficek J, Formica RN, Weng FL, Hazs RD, Thiessen Philbrook H, Parikh C. Utility of Applying Quality Assessment Tools for Kidneys With KDPI ≥80. Transplantation 2017, 101:1125-1133.
- Integrating APOL1 Gene Variants Into Renal Transplantation: Considerations Arising From the American Society of Transplantation Expert Conference.Newell KA, Formica RN, Gill JS, Schold JD, Allan JS, Covington SH, Wiseman AC, Chandraker A. Integrating APOL1 Gene Variants Into Renal Transplantation: Considerations Arising From the American Society of Transplantation Expert Conference. American Journal Of Transplantation : Official Journal Of The American Society Of Transplantation And The American Society Of Transplant Surgeons 2017, 17:901-911.
- Opportunities to Increase Availability of Deceased Donor Kidneys.Formica RN. Opportunities to Increase Availability of Deceased Donor Kidneys. Clinical Journal Of The American Society Of Nephrology : CJASN 2017, 12:871-873.
- Being Thoughtful about Desensitization.Formica RN, Kulkarni S. Being Thoughtful about Desensitization. Clinical Journal Of The American Society Of Nephrology : CJASN 2017, 12:1878-1880.
- Eculizumab Therapy for Chronic Antibody-Mediated Injury in Kidney Transplant Recipients: A Pilot Randomized Controlled Trial.Kulkarni S, Kirkiles-Smith NC, Deng YH, Formica RN, Moeckel G, Broecker V, Bow L, Tomlin R, Pober JS. Eculizumab Therapy for Chronic Antibody-Mediated Injury in Kidney Transplant Recipients: A Pilot Randomized Controlled Trial. American Journal Of Transplantation : Official Journal Of The American Society Of Transplantation And The American Society Of Transplant Surgeons 2017, 17:682-691.
- Changes in united network for organ sharing policy for simultaneous liver-kidney allocation.Merola J, Formica RN, Mulligan DC. Changes in united network for organ sharing policy for simultaneous liver-kidney allocation. Clinical Liver Disease 2017, 9:21-24.
- Simultaneous Liver-Kidney Transplantation: Impact on Liver Transplant Patients and the Kidney Transplant Waiting List.Miles CD, Westphal S, Liapakis A, Formica R. Simultaneous Liver-Kidney Transplantation: Impact on Liver Transplant Patients and the Kidney Transplant Waiting List. Current Transplantation Reports 2018, 5:1-6.
- The role of the kidney in combined liver-kidney transplantation.Formica RN. The role of the kidney in combined liver-kidney transplantation. Liver Transplantation : Official Publication Of The American Association For The Study Of Liver Diseases And The International Liver Transplantation Society 2018, 24:164-165.
- Analysis of Biomarkers Within the Initial 2 Years Posttransplant and 5-Year Kidney Transplant Outcomes: Results From Clinical Trials in Organ Transplantation-17.Faddoul G, Nadkarni GN, Bridges ND, Goebel J, Hricik DE, Formica R, Menon MC, Morrison Y, Murphy B, Newell K, Nickerson P, Poggio ED, Rush D, Heeger PS. Analysis of Biomarkers Within the Initial 2 Years Posttransplant and 5-Year Kidney Transplant Outcomes: Results From Clinical Trials in Organ Transplantation-17. Transplantation 2018, 102:673-680.
- Solid organ transplantation of viral hepatitis C positive donor organs into viral hepatitis C negative recipients.Liapakis A, Formica RN, Levitsky J. Solid organ transplantation of viral hepatitis C positive donor organs into viral hepatitis C negative recipients. Current Opinion In Organ Transplantation 2018, 23:257-263.
- And equal access for all? The future of deceased donor kidney allocation.Formica RN. And equal access for all? The future of deceased donor kidney allocation. American Journal Of Transplantation : Official Journal Of The American Society Of Transplantation And The American Society Of Transplant Surgeons 2018, 18:1837-1838.
- Report of National Kidney Foundation Consensus Conference to Decrease Kidney Discards.Cooper M, Formica R, Friedewald J, Hirose R, O'Connor K, Mohan S, Schold J, Axelrod D, Pastan S. Report of National Kidney Foundation Consensus Conference to Decrease Kidney Discards. Clinical Transplantation 2019, 33:e13419.
- ESKD Risk in Living Kidney Donors "Like Me".Newell KA, Formica RN. ESKD Risk in Living Kidney Donors "Like Me". Clinical Journal Of The American Society Of Nephrology : CJASN 2019, 14:970-971.
- Safety, pharmacokinetics, and pharmacodynamic activity of obinutuzumab, a type 2 anti-CD20 monoclonal antibody for the desensitization of candidates for renal transplant.Redfield RR, Jordan SC, Busque S, Vincenti F, Woodle ES, Desai N, Reed EF, Tremblay S, Zachary AA, Vo AA, Formica R, Schindler T, Tran H, Looney C, Jamois C, Green C, Morimoto A, Rajwanshi R, Schroeder A, Cascino MD, Brunetta P, Borie D. Safety, pharmacokinetics, and pharmacodynamic activity of obinutuzumab, a type 2 anti-CD20 monoclonal antibody for the desensitization of candidates for renal transplant. American Journal Of Transplantation : Official Journal Of The American Society Of Transplantation And The American Society Of Transplant Surgeons 2019, 19:3035-3045.
- Transplantation of Kidneys from HCV Viremic Donors in the United States: A Missed Opportunity to Inform Clinical Decision Making and Health Policy.Gill JS, Formica RN, Levitsky J. Transplantation of Kidneys from HCV Viremic Donors in the United States: A Missed Opportunity to Inform Clinical Decision Making and Health Policy. Journal Of The American Society Of Nephrology : JASN 2019, 30:1778-1780.
- Economic Evaluation of Extending Medicare Immunosuppressive Drug Coverage for Kidney Transplant Recipients in the Current Era.Kadatz M, Gill JS, Gill J, Formica RN, Klarenbach S. Economic Evaluation of Extending Medicare Immunosuppressive Drug Coverage for Kidney Transplant Recipients in the Current Era. Journal Of The American Society Of Nephrology : JASN 2020, 31:218-228.
- Should the United States employ free market practices to solve the hidden public health crisis of chronic kidney disease?Formica RN, Gill JS. Should the United States employ free market practices to solve the hidden public health crisis of chronic kidney disease? American Journal Of Transplantation : Official Journal Of The American Society Of Transplantation And The American Society Of Transplant Surgeons 2020, 20:1217-1218.
- Modulation of the antidepressant effects of ketamine by the mTORC1 inhibitor rapamycin.Abdallah CG, Averill LA, Gueorguieva R, Goktas S, Purohit P, Ranganathan M, Sherif M, Ahn KH, D'Souza DC, Formica R, Southwick SM, Duman RS, Sanacora G, Krystal JH. Modulation of the antidepressant effects of ketamine by the mTORC1 inhibitor rapamycin. Neuropsychopharmacology : Official Publication Of The American College Of Neuropsychopharmacology 2020, 45:990-997.
- The Broader Sharing of Deceased Donor Kidneys Is an Ethical and Legal Imperative.Klarman SE, Formica RN. The Broader Sharing of Deceased Donor Kidneys Is an Ethical and Legal Imperative. Journal Of The American Society Of Nephrology : JASN 2020, 31:1174-1176.
- Advancing American Kidney Health-New Opportunities for Collaborative Care.Rivara MB, Formica RN, Mehrotra R. Advancing American Kidney Health-New Opportunities for Collaborative Care. The American Journal Of Medicine 2020, 133:e335-e337.
- Outpatient Management of the Kidney Transplant Recipient during the SARS-CoV-2 Virus Pandemic.Gleeson SE, Formica RN, Marin EP. Outpatient Management of the Kidney Transplant Recipient during the SARS-CoV-2 Virus Pandemic. Clinical Journal Of The American Society Of Nephrology : CJASN 2020, 15:892-895.
- Levothyroxine-Induced Nonischemic Cardiomyopathy in a Kidney Transplant Candidate.Girone G, Cohen E, Hartell S, Formica R, Klarman S. Levothyroxine-Induced Nonischemic Cardiomyopathy in a Kidney Transplant Candidate. The Annals Of Pharmacotherapy 2020, 54:1260-1262.
- A call to action: Feasible strategies to reduce the discard of transplantable kidneys in the United States.Stewart ZA, Shah SA, Formica RN, Kandaswamy R, Paramesh AS, Friedman J, Squires R, Cooper M, Axelrod DA. A call to action: Feasible strategies to reduce the discard of transplantable kidneys in the United States. Clinical Transplantation 2020, 34:e13990.
- Physician and patient acceptance of policies to reduce kidney discard.Mehrotra S, Schantz K, Friedewald JJ, Ladner DP, Becker Y, Formica R, Barah M, Gu J, Gordon EJ. Physician and patient acceptance of policies to reduce kidney discard. Clinical Transplantation 2020, 34:e14054.
Clinical Trials
| Conditions | Study Title |
|---|---|
| Diseases of the Kidney & Urinary Tract; HIV/AIDS | HOPE in Action Prospective Multicenter, Clinical Trial of Deceased HIVD+ Kidney Transplants for HIV+ Recipients |
| Immune System; Infectious Diseases | Multicenter, Open Label, Phase 3 Trial of ATA129 for Solid Organ Transplant Subjects With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure of Rituximab or Rituximab and Chemotherapy (ALLELE Study) |